In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee:
Time and Date: 8:30 a.m.-3:00 p.m., EDT, March 30, 2016.Start Printed Page 11568
Place: Patriots Plaza I, 395 E Street SW., Room 9000, Washington, DC 20201.
Status: The meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 33 people. The public is welcome to participate during the public comment period, 12:30 p.m.-12:45 p.m. EDT, March 30, 2016. Please note that the public comment period ends at the time indicated above or following the last call for comments, whichever is earlier. Members of the public who want to comment must sign up by providing their name by mail, email, or telephone, at the addresses provided below by March 18, 2016. Each commenter will be provided up to five minutes for comment. A limited number of time slots are available and will be assigned on a first come-first served basis. Written comments will be accepted to attendees who do not have the opportunity to speak at the meeting, and will also be accepted from those unable to attend the public session. The meeting is also open to the public via webcast. If you wish to attend in person or by webcast, please see the NIOSH Web site to register (http://www.cdc.gov/niosh/bsc/) or call (404-498-2539) at least five business days in advance of the meeting. Teleconference is available toll-free; please dial (888) 397-9578, Participant Pass Code 63257516.
Purpose: The Secretary, the Assistant Secretary for Health, and by delegation the Director, Centers for Disease Control and Prevention, are authorized under Sections 301 and 308 of the Public Health Service Act to conduct directly or by grants or contracts, research, experiments, and demonstrations relating to occupational safety and health and to mine health. The Board of Scientific Counselors provides guidance to the Director, National Institute for Occupational Safety and Health on research and prevention programs. Specifically, the Board provides guidance on the Institute's research activities related to developing and evaluating hypotheses, systematically documenting findings and disseminating results. The Board evaluates the degree to which the activities of the National Institute for Occupational Safety and Health: (1) Conform to appropriate scientific standards, (2) address current, relevant needs, and (3) produce intended results.
Matters for Discussion: NIOSH Director's update; Diacetyl in Coffee Roasting; Burden, Need, and Impact Framework for Research and National Occupational Research Agenda (NORA) 3; Translation Research, and the NIOSH Center for Maritime Safety and Health Studies.
Agenda items are subject to change as priorities dictate.
An agenda is also posted on the NIOSH Web site (http://www.cdc.gov/niosh/bsc/). Members of the public who wish to address the NIOSH BSC are requested to contact the Executive Secretary for scheduling purposes (see contact information below). Alternatively, written comments to the BSC may be submitted via an on-line form at the following Web site: http://www.cdc.gov/niosh/bsc/contact.html.
Contact Person for More Information: Paul J. Middendorf, Ph.D., Executive Secretary, BSC, NIOSH, CDC, 1600 Clifton Road NE., MS-E20, Atlanta, GA 30329-4018, telephone (404)498-2500, fax (404)498-2526.
The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2016-04713 Filed 3-3-16; 8:45 am]
BILLING CODE 4163-18-P